Jubilant Pharmo

{
  "main_header": {
    "sid": 525933,
    "name": "Jubilant Pharmo",
    "stock_name": "Jubilant Pharmo",
    "full_name": "Jubilant Pharmova Ltd",
    "name_url": "stocks-analysis/jubilant-pharmo",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,063.45",
    "chg": 4.85,
    "chgp": "0.46%",
    "dir": 1,
    "prev_price": "1,058.60",
    "mcapval": "16,901.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530019,
    "symbol": "JUBLPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE700A01033",
    "curr_date": "Sep 24, 03:30 PM",
    "curr_time": "22:17 PM",
    "last_traded_at": "Sep 24, 03:30 PM IST",
    "bse_nse_vol": "1.25 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jubilant-pharmo-525933-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4202874",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_technicaldot_4202874.png",
        "date": "2026-09-24 08:01:51",
        "description": "Jubilant Pharmova Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock exhibits a complex interplay of bullish and bearish signals across key technical indicators, warranting a detailed analysis for investors navigating this evolving landscape."
      },
      {
        "title": "Jubilant Pharmova Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-sell-4202368",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_mojoScore_4202368.png",
        "date": "2026-09-23 10:10:25",
        "description": "Jubilant Pharmova Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4201678",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_technicaldot_4201678.png",
        "date": "2026-09-23 08:01:57",
        "description": "Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish trend to a sideways pattern, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a 2.03% gain on 23 Sep 2026, the stock’s technical landscape remains nuanced, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators."
      },
      {
        "title": "Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4200297",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_technicaldot_4200297.png",
        "date": "2026-09-22 08:03:38",
        "description": "Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish signals on longer-term indicators, the stock’s daily moving averages and recent price action suggest caution for investors amid mixed technical readings and a recent downgrade in its Mojo Grade to Sell."
      },
      {
        "title": "Jubilant Pharmova Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-4199046",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_technicaldot_4199046.png",
        "date": "2026-09-21 08:01:43",
        "description": "Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent 5.44% daily gain to ₹1,067.15, alongside mixed readings from MACD, RSI, and moving averages, suggests a cautious but potentially stabilising outlook for this pharmaceuticals and biotechnology small-cap."
      },
      {
        "title": "Jubilant Pharmova Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-sell-4190960",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_mojoScore_4190960.png",
        "date": "2026-09-12 10:10:36",
        "description": "Jubilant Pharmova Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Jubilant Pharmova Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-4185581",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_technicaldot_4185581.png",
        "date": "2026-09-08 08:03:42",
        "description": "Jubilant Pharmova Ltd has exhibited a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook as of early September 2026. Despite a day gain of 3.14%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical parameter changes, price momentum, and how these factors compare with broader market trends and the pharmaceutical sector."
      },
      {
        "title": "Jubilant Pharmova Gains 4.73%: Valuation Upgrades and Mixed Financial Signals Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-gains-473-valuation-upgrades-and-mixed-financial-signals-shape-the-week-4183873",
        "imagepath": "",
        "date": "2026-09-05 17:06:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>31 Aug:</strong> MarketsMOJO upgrades Jubilant Pharmova Ltd rating to Sell on improved valuation</p>\n                    <p><strong>1 Sep:</strong> Stock surges 2.95% amid valuation upgrade and relative sector appeal</p>\n                    <p><strong>2 Sep:</strong> Valuation metrics show improvement despite mixed market returns</p>\n                    <p><strong>4 Sep:</strong> Stock closes the week at Rs.923.75, up 1.92% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.882.05</div></div>\n                    <div class=\"stat-item\"><div class=..."
      },
      {
        "title": "Jubilant Pharmova Ltd Valuation Improves Amid Mixed Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-valuation-improves-amid-mixed-market-returns-4178374",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/JubilantPharmov_valuationdot_4178374.png",
        "date": "2026-09-02 08:00:49",
        "description": "Jubilant Pharmova Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a challenging year-to-date performance relative to the broader Sensex. This article analyses the recent changes in key valuation metrics, compares the company’s standing against its pharmaceutical peers, and assesses the implications for investors navigating the small-cap pharmaceutical sector."
      }
    ],
    "total": 436,
    "sid": "525933",
    "stock_news_url": "https://www.marketsmojo.com/news/jubilant-pharmova-525933"
  },
  "announcements": [
    {
      "caption": "Update On USFDA Spokane",
      "datetime": "11-Sep-2026",
      "details": "Update on USFDA Spokane",
      "source": "BSE"
    },
    {
      "caption": "Receipt Of Show Cause Notice By Jubilant Pharmova Limited - GST",
      "datetime": "01-Sep-2026",
      "details": "Receipt of Show Cause Notice by Jubilant Pharmova Limited - GST",
      "source": "BSE"
    },
    {
      "caption": "Receipt Of Show Cause Notice - Jubilant Generics Limited",
      "datetime": "28-Aug-2026",
      "details": "Receipt of Show Cause Notice - Jubilant Generics Limited",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jubilant Pharmova Ltd has declared <strong>500%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jubilant Pharmova Ltd has announced <strong>1:5</strong> stock split, ex-date: 17 Mar 06",
          "dt": "2006-03-17",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-24 08:01:51

Jubilant Pharmova Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock exhibits a complex interplay of bullish and bearish signals across key technical indicators, warranting a detailed analysis for investors navigating this evolving landscape.

Read full news article

Jubilant Pharmova Ltd is Rated Sell

2026-09-23 10:10:25

Jubilant Pharmova Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-23 08:01:57

Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish trend to a sideways pattern, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a 2.03% gain on 23 Sep 2026, the stock’s technical landscape remains nuanced, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators.

Read full news article

Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-22 08:03:38

Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish signals on longer-term indicators, the stock’s daily moving averages and recent price action suggest caution for investors amid mixed technical readings and a recent downgrade in its Mojo Grade to Sell.

Read full news article

Jubilant Pharmova Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals

2026-09-21 08:01:43

Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. The stock’s recent 5.44% daily gain to ₹1,067.15, alongside mixed readings from MACD, RSI, and moving averages, suggests a cautious but potentially stabilising outlook for this pharmaceuticals and biotechnology small-cap.

Read full news article

Jubilant Pharmova Ltd is Rated Sell

2026-09-12 10:10:36

Jubilant Pharmova Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Jubilant Pharmova Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-09-08 08:03:42

Jubilant Pharmova Ltd has exhibited a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook as of early September 2026. Despite a day gain of 3.14%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical parameter changes, price momentum, and how these factors compare with broader market trends and the pharmaceutical sector.

Read full news article

Jubilant Pharmova Gains 4.73%: Valuation Upgrades and Mixed Financial Signals Shape the Week

2026-09-05 17:06:07

Key Events This Week

31 Aug: MarketsMOJO upgrades Jubilant Pharmova Ltd rating to Sell on improved valuation

1 Sep: Stock surges 2.95% amid valuation upgrade and relative sector appeal

2 Sep: Valuation metrics show improvement despite mixed market returns

4 Sep: Stock closes the week at Rs.923.75, up 1.92% on the day

Week Open

Rs.882.05

Read full news article

Jubilant Pharmova Ltd Valuation Improves Amid Mixed Market Returns

2026-09-02 08:00:49

Jubilant Pharmova Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, despite a challenging year-to-date performance relative to the broader Sensex. This article analyses the recent changes in key valuation metrics, compares the company’s standing against its pharmaceutical peers, and assesses the implications for investors navigating the small-cap pharmaceutical sector.

Read full news article

View All News